Literature DB >> 23524975

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma.

Wiebke Hansen1.   

Abstract

Regulatory T cells (Tregs) interfere with antitumor immune responses, hence facilitating oncogenesis and tumor progression. Our recent findings indicate that neuropilin 1, which is highly expressed by Tregs, mediates the infiltration of these cells into the tumor in a vascular endothelial growth factor (VEGF)-dependent manner, thereby contributing to cancer-associated immunosuppression.

Entities:  

Keywords:  T-cell migration; melanoma; regulatory T cells

Year:  2013        PMID: 23524975      PMCID: PMC3601175          DOI: 10.4161/onci.23039

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  8 in total

Review 1.  Mechanisms of suppression by suppressor T cells.

Authors:  Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

Review 2.  Regulatory T cells in tumor immunity.

Authors:  Hiroyoshi Nishikawa; Shimon Sakaguchi
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

4.  Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration.

Authors:  Ling Wang; Huiyan Zeng; Ping Wang; Shay Soker; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2003-09-26       Impact factor: 5.157

5.  Neuropilin-1: a surface marker of regulatory T cells.

Authors:  Dunja Bruder; Michael Probst-Kepper; Astrid M Westendorf; Robert Geffers; Stefan Beissert; Karin Loser; Harald von Boehmer; Jan Buer; Wiebke Hansen
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

6.  Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.

Authors:  Wiebke Hansen; Marina Hutzler; Simone Abel; Christina Alter; Christian Stockmann; Stefanie Kliche; Juliane Albert; Tim Sparwasser; Shimon Sakaguchi; Astrid M Westendorf; Dirk Schadendorf; Jan Buer; Iris Helfrich
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

7.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.

Authors:  Mahesh Yadav; Cedric Louvet; Dan Davini; James M Gardner; Marc Martinez-Llordella; Samantha Bailey-Bucktrout; Bryan A Anthony; Francis M Sverdrup; Richard Head; Daniel J Kuster; Peter Ruminski; David Weiss; David Von Schack; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

8.  Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.

Authors:  Jonathan M Weiss; Angelina M Bilate; Michael Gobert; Yi Ding; Maria A Curotto de Lafaille; Christopher N Parkhurst; Huizhong Xiong; Jayashree Dolpady; Alan B Frey; Maria Grazia Ruocco; Yi Yang; Stefan Floess; Jochen Huehn; Soyoung Oh; Ming O Li; Rachel E Niec; Alexander Y Rudensky; Michael L Dustin; Dan R Littman; Juan J Lafaille
Journal:  J Exp Med       Date:  2012-09-10       Impact factor: 14.307

  8 in total
  10 in total

1.  Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.

Authors:  Si Yang; Ying Wu; Yujiao Deng; Linghui Zhou; Pengtao Yang; Yi Zheng; Dai Zhang; Zhen Zhai; Na Li; Qian Hao; Dingli Song; Huafeng Kang; Zhijun Dai
Journal:  Oncoimmunology       Date:  2019-10-03       Impact factor: 8.110

Review 2.  Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.

Authors:  Hiroshi Yano; Lawrence P Andrews; Creg J Workman; Dario A A Vignali
Journal:  Immunology       Date:  2019-06-03       Impact factor: 7.397

3.  Relationship between neuropilin-1 expression and prognosis, according to gastric cancer histology.

Authors:  Ho Seok Seo; Jiyeon Hyeon; In Hye Song; Han Hong Lee
Journal:  J Mol Histol       Date:  2020-04-02       Impact factor: 2.611

4.  Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway.

Authors:  Jillian C Nissen; David L Selwood; Stella E Tsirka
Journal:  J Neurochem       Date:  2013-09-18       Impact factor: 5.372

5.  A prospective evaluation of the role of Vascular Endothelial Growth Factor (VEGF) and the immune system in stage III/IV melanoma.

Authors:  Nicole Marie Agostino; Christine Saraceni; Hope Kincaid; Wenjing Shi; Wendy Kay Nevala; Svetomir Markovic; Suresh G Nair
Journal:  Springerplus       Date:  2015-04-17

6.  Architecture and hydration of the arginine-binding site of neuropilin-1.

Authors:  Filipa Mota; Constantina Fotinou; Rohini R Rana; A W Edith Chan; Tamas Yelland; Mohamed T Arooz; Andrew P O'Leary; Jennie Hutton; Paul Frankel; Ian Zachary; David Selwood; Snezana Djordjevic
Journal:  FEBS J       Date:  2018-02-25       Impact factor: 5.542

7.  Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165.

Authors:  Bartlomiej Fedorczyk; Piotr F J Lipiński; Anna K Puszko; Dagmara Tymecka; Beata Wilenska; Wioleta Dudka; Gerard Y Perret; Rafal Wieczorek; Aleksandra Misicka
Journal:  Molecules       Date:  2019-05-06       Impact factor: 4.411

Review 8.  Reverting Immune Suppression to Enhance Cancer Immunotherapy.

Authors:  Bella S Guerrouahen; Cristina Maccalli; Chiara Cugno; Sergio Rutella; Emmanuel T Akporiaye
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

9.  Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.

Authors:  Rui-Lian Chen; Jing-Xu Zhou; Yang Cao; Ling-Ling Sun; Shan Su; Xiao-Jie Deng; Jie-Tao Lin; Zhi-Wei Xiao; Zhuang-Zhong Chen; Si-Yu Wang; Li-Zhu Lin
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

10.  Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma.

Authors:  Chao Deng; Hang Guo; Dongliang Yan; Tao Liang; Xuxiao Ye; Zuowei Li
Journal:  Biomed Res Int       Date:  2021-04-15       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.